Mobidiag

Mobidiag is rated 3 out of 5 in the category molecular diagnostics for infectious diseases. Read and write reviews about Mobidiag. Mobidiag is a biotechnology company specialized in development and commercialization of molecular diagnostics solutions used by clinical laboratories for detection of infectious diseases, including antibiotic resistances. Following the strategic and successful corporate three-way merger in 2013, complementing technologies and products were brought together to answer customer needs in the field of infectious disease diagnostics. Currently, Mobidiag offers 2 product lines: - the Amplidiag® solution, a qPCR-based multiplex based product line comprising the Amplidiag® Easy automated platform and a large panel of gastrointestinal disease tests for semi-automation of overall lab workflow. The Amplidiag products target large laboratories with high volume screening requirements. - the innovative Novodiag®, a fully automated molecular diagnostics solution for both syndromic and targeted testing of infectious diseases. Novodiag is particularly well suited for small to medium-sized laboratories as well as decentralized labs thanks to its simple on-demand capacity. As a result, combining both Amplidiag and Novodiag solutions, Mobidiag covers all microbiology laboratories requirements no matter their size, throughput and centralized/decentralized organization. Follow us on LinkedIn, Twitter, Facebook and Instagram for daily updates! According to the latest GDPR requirements, visit our privacy policy page to learn more about how we collect your data and feel free to contact us if needed at [email protected]: http://mobidiag.com/assets/uploads/2018/05/mobidiag-privacy-policy.pdf